Selected article for: "ACE inhibitor and SARS infection"

Author: Daniel J Butler; Christopher Mozsary; Cem Meydan; David C Danko; Jonathan Foox; Joel Rosiene; Alon Shaiber; Ebrahim Afshinnekoo; Matthew MacKay; Fritz J Sedlazeck; Nikolay A Ivanov; Maria A Sierra; Diana Pohle; Michael Zeitz; Vijendra Ramlall; Undina Gisladottir; Craig D Westover; Krista Ryon; Benjamin Young; Chandrima Bhattacharya; Phyllis Ruggiero; Bradley W Langhorst; Nathan A Tanner; Justyn Gawrys; Dmitry Meleshko; Dong Xu; Jenny Xiang; Angelika Iftner; Daniela Bezdan; John Sipley; Lin Cong; Arryn Craney; Priya Velu; Ari Melnick; Iman A Hajirasouliha; Thomas Iftner; Mirella Salvatore; Massimo Loda; Lars F Westblade; Shawn Levy; Melissa Cushing; Nicholas P Tatonetti; Marcin Imielinski; Hanna Rennert; Christopher Mason
Title: Host, Viral, and Environmental Transcriptome Profiles of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • Document date: 2020_4_20
  • ID: kyoa5gsf_71
    Snippet: We compared usage of ACE inhibitors in an observational cohort analysis of 8,278 patients with suspected SARS-CoV-2 infection (4,574 of which tested positive). ACE inhibitors are commonly taken continuously for several years (Bonarjee et al., 2001) . We defined a cohort of ACE inhibitor-exposed patients as those that have an ACE inhibitor prescription order sometime after January 1st, 2019. We compared the frequency of ACE inhibitor exposure in t.....
    Document: We compared usage of ACE inhibitors in an observational cohort analysis of 8,278 patients with suspected SARS-CoV-2 infection (4,574 of which tested positive). ACE inhibitors are commonly taken continuously for several years (Bonarjee et al., 2001) . We defined a cohort of ACE inhibitor-exposed patients as those that have an ACE inhibitor prescription order sometime after January 1st, 2019. We compared the frequency of ACE inhibitor exposure in three cohort comparisons: i. SARS-CoV-2 tested positive patients versus SARS-CoV-2 tested negative patients, ii. SARS-CoV-2 positive patients who require mechanical ventilation versus those who did not, and iii. SARS-CoV-2 positive patient survival versus death.

    Search related documents:
    Co phrase search for related documents
    • ACE inhibitor and mechanical ventilation: 1, 2, 3, 4, 5
    • ACE inhibitor and positive patient: 1, 2
    • ACE inhibitor and positive test: 1, 2, 3, 4
    • ACE inhibitor and positive test SARS infection: 1
    • ACE inhibitor and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • ACE inhibitor exposure and cohort analysis: 1
    • ACE inhibitor exposure and positive patient: 1
    • ACE inhibitor exposure and positive test: 1
    • ACE inhibitor exposure and positive test SARS infection: 1
    • ACE inhibitor exposure and SARS infection: 1
    • ACE inhibitor exposure frequency and cohort analysis: 1
    • ACE inhibitor exposure frequency and positive patient: 1